1. Chen, Doris, Yu, Wanjia, Aitken, Laura, Gunn-Moore, Frank. 2021. Willin/FRMD6: A Multi-Functional Neuronal Protein Associated with Alzheimer's Disease. In Cells, 10, . doi:10.3390/cells10113024. https://pubmed.ncbi.nlm.nih.gov/34831245/
2. Haldrup, Jakob, Strand, Siri H, Cieza-Borrella, Clara, Kote-Jarai, Zsofia, Sorensen, Karina D. 2020. FRMD6 has tumor suppressor functions in prostate cancer. In Oncogene, 40, 763-776. doi:10.1038/s41388-020-01548-w. https://pubmed.ncbi.nlm.nih.gov/33249427/
3. Wang, Tianzhuo, Guo, Huiying, Zhang, Lei, Zhang, Hongquan, Zhan, Jun. 2023. FERM domain-containing protein FRMD6 activates the mTOR signaling pathway and promotes lung cancer progression. In Frontiers of medicine, 17, 714-728. doi:10.1007/s11684-022-0959-5. https://pubmed.ncbi.nlm.nih.gov/37060526/
4. Sun, Wen, Lei, Xiangxiang, Lu, Qiliang, Huang, Dongsheng, Zhang, Yaping. 2023. LncRNA FRMD6-AS1 promotes hepatocellular carcinoma cell migration and stemness by regulating SENP1/HIF-1α axis. In Pathology, research and practice, 243, 154377. doi:10.1016/j.prp.2023.154377. https://pubmed.ncbi.nlm.nih.gov/36827886/
5. Hong, Mun-Gwan, Reynolds, Chandra A, Feldman, Adina L, Pedersen, Nancy L, Prince, Jonathan A. 2012. Genome-wide and gene-based association implicates FRMD6 in Alzheimer disease. In Human mutation, 33, 521-9. doi:10.1002/humu.22009. https://pubmed.ncbi.nlm.nih.gov/22190428/
6. Wang, Wei, Zhao, Chang'an, Quan, Fang, Shao, Yuan, Liu, Lifeng. 2021. FERM domain-containing protein 6 exerts a tumor-inhibiting role in thyroid cancer by antagonizing oncogenic YAP1. In BioFactors (Oxford, England), 48, 428-441. doi:10.1002/biof.1791. https://pubmed.ncbi.nlm.nih.gov/34669997/
智鼠故事 
